nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—SULT1A1—forebrain—attention deficit hyperactivity disorder	0.0311	0.0438	CbGeAlD
Tamoxifen—DHCR7—forebrain—attention deficit hyperactivity disorder	0.0221	0.0311	CbGeAlD
Tamoxifen—FMO1—forebrain—attention deficit hyperactivity disorder	0.0221	0.0311	CbGeAlD
Tamoxifen—EBPL—nervous system—attention deficit hyperactivity disorder	0.0213	0.0299	CbGeAlD
Tamoxifen—EBPL—central nervous system—attention deficit hyperactivity disorder	0.0205	0.0288	CbGeAlD
Tamoxifen—EBPL—cerebellum—attention deficit hyperactivity disorder	0.02	0.0281	CbGeAlD
Tamoxifen—ESRRA—cardiovascular system—attention deficit hyperactivity disorder	0.0184	0.0259	CbGeAlD
Tamoxifen—SULT1A1—nervous system—attention deficit hyperactivity disorder	0.0169	0.0238	CbGeAlD
Tamoxifen—SULT1A1—central nervous system—attention deficit hyperactivity disorder	0.0163	0.0229	CbGeAlD
Tamoxifen—EBPL—brain—attention deficit hyperactivity disorder	0.0163	0.0229	CbGeAlD
Tamoxifen—SULT1A1—cerebellum—attention deficit hyperactivity disorder	0.0159	0.0224	CbGeAlD
Tamoxifen—Diethylstilbestrol—COMT—attention deficit hyperactivity disorder	0.0155	0.29	CrCbGaD
Tamoxifen—DHCR7—midbrain—attention deficit hyperactivity disorder	0.0146	0.0206	CbGeAlD
Tamoxifen—ESRRA—midbrain—attention deficit hyperactivity disorder	0.0144	0.0202	CbGeAlD
Tamoxifen—ESR2—forebrain—attention deficit hyperactivity disorder	0.0131	0.0184	CbGeAlD
Tamoxifen—SULT1A1—brain—attention deficit hyperactivity disorder	0.0129	0.0182	CbGeAlD
Tamoxifen—CES1—cardiovascular system—attention deficit hyperactivity disorder	0.0128	0.018	CbGeAlD
Tamoxifen—DHCR7—nervous system—attention deficit hyperactivity disorder	0.012	0.0169	CbGeAlD
Tamoxifen—FMO1—nervous system—attention deficit hyperactivity disorder	0.012	0.0169	CbGeAlD
Tamoxifen—ESRRA—nervous system—attention deficit hyperactivity disorder	0.0118	0.0166	CbGeAlD
Tamoxifen—DHCR7—central nervous system—attention deficit hyperactivity disorder	0.0116	0.0163	CbGeAlD
Tamoxifen—FMO1—central nervous system—attention deficit hyperactivity disorder	0.0116	0.0163	CbGeAlD
Tamoxifen—ESRRA—central nervous system—attention deficit hyperactivity disorder	0.0114	0.016	CbGeAlD
Tamoxifen—DHCR7—cerebellum—attention deficit hyperactivity disorder	0.0113	0.0159	CbGeAlD
Tamoxifen—ESRRA—cerebellum—attention deficit hyperactivity disorder	0.0111	0.0157	CbGeAlD
Tamoxifen—ESR2—cardiovascular system—attention deficit hyperactivity disorder	0.0111	0.0155	CbGeAlD
Tamoxifen—FMO3—nervous system—attention deficit hyperactivity disorder	0.0104	0.0146	CbGeAlD
Tamoxifen—CYP19A1—forebrain—attention deficit hyperactivity disorder	0.0103	0.0145	CbGeAlD
Tamoxifen—FMO3—central nervous system—attention deficit hyperactivity disorder	0.01	0.0141	CbGeAlD
Tamoxifen—DHCR7—brain—attention deficit hyperactivity disorder	0.00918	0.0129	CbGeAlD
Tamoxifen—FMO1—brain—attention deficit hyperactivity disorder	0.00918	0.0129	CbGeAlD
Tamoxifen—ESRRA—brain—attention deficit hyperactivity disorder	0.00904	0.0127	CbGeAlD
Tamoxifen—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00899	0.168	CrCbGaD
Tamoxifen—ESR1—forebrain—attention deficit hyperactivity disorder	0.00895	0.0126	CbGeAlD
Tamoxifen—CES1—nervous system—attention deficit hyperactivity disorder	0.0082	0.0115	CbGeAlD
Tamoxifen—CYP1B1—cardiovascular system—attention deficit hyperactivity disorder	0.00814	0.0115	CbGeAlD
Tamoxifen—FMO3—brain—attention deficit hyperactivity disorder	0.00794	0.0112	CbGeAlD
Tamoxifen—CES1—central nervous system—attention deficit hyperactivity disorder	0.00789	0.0111	CbGeAlD
Tamoxifen—ESR1—cardiovascular system—attention deficit hyperactivity disorder	0.00757	0.0106	CbGeAlD
Tamoxifen—ESR2—nervous system—attention deficit hyperactivity disorder	0.0071	0.00998	CbGeAlD
Tamoxifen—ESR2—central nervous system—attention deficit hyperactivity disorder	0.00683	0.00961	CbGeAlD
Tamoxifen—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00671	0.00944	CbGeAlD
Tamoxifen—SIGMAR1—midbrain—attention deficit hyperactivity disorder	0.00669	0.00941	CbGeAlD
Tamoxifen—ESR2—cerebellum—attention deficit hyperactivity disorder	0.00668	0.00939	CbGeAlD
Tamoxifen—CES1—brain—attention deficit hyperactivity disorder	0.00627	0.00881	CbGeAlD
Tamoxifen—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.0056	0.00787	CbGeAlD
Tamoxifen—CYP19A1—nervous system—attention deficit hyperactivity disorder	0.00559	0.00787	CbGeAlD
Tamoxifen—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00554	0.00779	CbGeAlD
Tamoxifen—CYP2A6—brain—attention deficit hyperactivity disorder	0.00545	0.00767	CbGeAlD
Tamoxifen—ESR2—brain—attention deficit hyperactivity disorder	0.00543	0.00763	CbGeAlD
Tamoxifen—CYP19A1—central nervous system—attention deficit hyperactivity disorder	0.00539	0.00757	CbGeAlD
Tamoxifen—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00525	0.00739	CbGeAlD
Tamoxifen—CYP1B1—nervous system—attention deficit hyperactivity disorder	0.00523	0.00735	CbGeAlD
Tamoxifen—SIGMAR1—cerebellum—attention deficit hyperactivity disorder	0.00517	0.00728	CbGeAlD
Tamoxifen—CYP1B1—central nervous system—attention deficit hyperactivity disorder	0.00503	0.00708	CbGeAlD
Tamoxifen—CYP1B1—cerebellum—attention deficit hyperactivity disorder	0.00492	0.00692	CbGeAlD
Tamoxifen—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00492	0.00692	CbGeAlD
Tamoxifen—ESR1—nervous system—attention deficit hyperactivity disorder	0.00486	0.00684	CbGeAlD
Tamoxifen—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00474	0.00666	CbGeAlD
Tamoxifen—ESR1—central nervous system—attention deficit hyperactivity disorder	0.00468	0.00658	CbGeAlD
Tamoxifen—ESR1—cerebellum—attention deficit hyperactivity disorder	0.00457	0.00643	CbGeAlD
Tamoxifen—CYP19A1—brain—attention deficit hyperactivity disorder	0.00428	0.00601	CbGeAlD
Tamoxifen—SIGMAR1—brain—attention deficit hyperactivity disorder	0.0042	0.00591	CbGeAlD
Tamoxifen—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00409	0.0766	CrCbGaD
Tamoxifen—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00401	0.0751	CrCbGaD
Tamoxifen—CYP1B1—brain—attention deficit hyperactivity disorder	0.004	0.00562	CbGeAlD
Tamoxifen—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.00397	0.0743	CrCbGaD
Tamoxifen—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00383	0.0718	CrCbGaD
Tamoxifen—ESR1—brain—attention deficit hyperactivity disorder	0.00372	0.00523	CbGeAlD
Tamoxifen—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.0037	0.0052	CbGeAlD
Tamoxifen—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00366	0.00515	CbGeAlD
Tamoxifen—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00359	0.00505	CbGeAlD
Tamoxifen—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00356	0.00501	CbGeAlD
Tamoxifen—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00354	0.00497	CbGeAlD
Tamoxifen—Promazine—DRD4—attention deficit hyperactivity disorder	0.00353	0.066	CrCbGaD
Tamoxifen—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00346	0.00486	CbGeAlD
Tamoxifen—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00337	0.00474	CbGeAlD
Tamoxifen—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00325	0.00456	CbGeAlD
Tamoxifen—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00317	0.00446	CbGeAlD
Tamoxifen—CYP2C8—brain—attention deficit hyperactivity disorder	0.00306	0.0043	CbGeAlD
Tamoxifen—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00299	0.00421	CbGeAlD
Tamoxifen—Promazine—DRD1—attention deficit hyperactivity disorder	0.00298	0.0559	CrCbGaD
Tamoxifen—ABCG2—brain—attention deficit hyperactivity disorder	0.00298	0.00419	CbGeAlD
Tamoxifen—CYP1A1—brain—attention deficit hyperactivity disorder	0.00283	0.00397	CbGeAlD
Tamoxifen—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.00277	0.0519	CrCbGaD
Tamoxifen—CYP2B6—brain—attention deficit hyperactivity disorder	0.00275	0.00386	CbGeAlD
Tamoxifen—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00271	0.00381	CbGeAlD
Tamoxifen—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00267	0.00375	CbGeAlD
Tamoxifen—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00261	0.00367	CbGeAlD
Tamoxifen—CYP2E1—brain—attention deficit hyperactivity disorder	0.00258	0.00362	CbGeAlD
Tamoxifen—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00257	0.00361	CbGeAlD
Tamoxifen—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00251	0.00353	CbGeAlD
Tamoxifen—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00234	0.00328	CbGeAlD
Tamoxifen—Promazine—DRD2—attention deficit hyperactivity disorder	0.0021	0.0394	CrCbGaD
Tamoxifen—CYP2D6—brain—attention deficit hyperactivity disorder	0.00204	0.00287	CbGeAlD
Tamoxifen—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00192	0.0027	CbGeAlD
Tamoxifen—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00185	0.0026	CbGeAlD
Tamoxifen—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00181	0.00254	CbGeAlD
Tamoxifen—Promazine—HTR2A—attention deficit hyperactivity disorder	0.00163	0.0304	CrCbGaD
Tamoxifen—ABCB1—brain—attention deficit hyperactivity disorder	0.00147	0.00206	CbGeAlD
Tamoxifen—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000369	0.00157	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000367	0.00156	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000366	0.00156	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000365	0.00155	CbGpPWpGaD
Tamoxifen—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000362	0.00154	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000347	0.00147	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000344	0.00146	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000343	0.00146	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000343	0.00146	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000337	0.00143	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000328	0.00139	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000327	0.00139	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000326	0.00138	CbGpPWpGaD
Tamoxifen—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000324	0.00137	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—COMT—attention deficit hyperactivity disorder	0.000322	0.00137	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000322	0.00137	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00032	0.00136	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000315	0.00134	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000315	0.00134	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000314	0.00133	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.00132	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000311	0.00132	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000308	0.00131	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000302	0.00128	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.0003	0.00127	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000299	0.00127	CbGpPWpGaD
Tamoxifen—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000298	0.00126	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000297	0.00126	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000295	0.00125	CbGpPWpGaD
Tamoxifen—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000295	0.00125	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000292	0.00124	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000288	0.00122	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000282	0.0012	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000281	0.00119	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000276	0.00117	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000274	0.00116	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000266	0.00113	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000261	0.00111	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000256	0.00109	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000254	0.00108	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000254	0.00108	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000253	0.00107	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000253	0.00107	CbGpPWpGaD
Tamoxifen—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000252	0.00107	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000249	0.00106	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000248	0.00105	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000246	0.00105	CbGpPWpGaD
Tamoxifen—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000246	0.00104	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000242	0.00103	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000241	0.00102	CbGpPWpGaD
Tamoxifen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000241	0.00102	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00024	0.00102	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000239	0.00101	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000231	0.000982	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00022	0.000934	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000208	0.000882	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000207	0.000878	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000206	0.000876	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000203	0.000861	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000202	0.000858	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000199	0.000844	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000197	0.000837	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000196	0.000831	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000195	0.000826	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000192	0.000817	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000191	0.00081	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000191	0.00081	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000188	0.000797	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000184	0.00078	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000184	0.00078	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000182	0.000775	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000181	0.000767	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000179	0.00076	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000178	0.000754	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000174	0.000741	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000174	0.000738	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000174	0.000737	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—EP300—attention deficit hyperactivity disorder	0.000173	0.000734	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000168	0.000713	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000167	0.00071	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000167	0.00071	CbGpPWpGaD
Tamoxifen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000166	0.000704	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000166	0.000703	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000166	0.000703	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000164	0.000698	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000164	0.000696	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000163	0.000692	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—COMT—attention deficit hyperactivity disorder	0.000153	0.00065	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000153	0.000649	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000153	0.000648	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000152	0.000646	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000152	0.000645	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000152	0.000645	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000152	0.000643	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00015	0.000638	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000149	0.000634	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000149	0.000632	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000148	0.000626	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000147	0.000624	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000616	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000141	0.000597	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00014	0.000594	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000139	0.00059	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—EP300—attention deficit hyperactivity disorder	0.000138	0.000587	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000137	0.000584	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000134	0.000569	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000134	0.000567	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000132	0.000562	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000131	0.000556	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.00054	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000126	0.000536	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000126	0.000535	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000123	0.000524	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000123	0.000521	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000123	0.00052	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000123	0.00052	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000122	0.000519	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000121	0.000515	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000121	0.000512	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00012	0.000509	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00012	0.000509	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00012	0.000508	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00012	0.000508	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000118	0.000501	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000118	0.0005	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000116	0.000491	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000116	0.000491	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000115	0.000487	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000114	0.000485	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000113	0.00048	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000113	0.00048	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000112	0.000476	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000111	0.000473	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000111	0.000473	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000111	0.000473	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000111	0.000469	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000111	0.000469	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00011	0.000466	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00011	0.000465	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000109	0.000461	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000107	0.000456	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000107	0.000455	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000106	0.000451	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000105	0.000444	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000104	0.00044	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000104	0.00044	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000103	0.000439	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000102	0.000433	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000101	0.00043	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000101	0.000427	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.0001	0.000426	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.0001	0.000425	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	9.97e-05	0.000423	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.8e-05	0.000416	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.59e-05	0.000407	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.57e-05	0.000406	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.49e-05	0.000403	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.32e-05	0.000396	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	9.26e-05	0.000393	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.26e-05	0.000393	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	9.2e-05	0.000391	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.14e-05	0.000388	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.13e-05	0.000388	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.11e-05	0.000387	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	9.11e-05	0.000387	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.05e-05	0.000384	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	9.04e-05	0.000384	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.04e-05	0.000384	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—EP300—attention deficit hyperactivity disorder	8.91e-05	0.000378	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.89e-05	0.000377	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.61e-05	0.000366	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	8.52e-05	0.000362	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.52e-05	0.000362	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.47e-05	0.00036	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	8.44e-05	0.000358	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.44e-05	0.000358	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	8.38e-05	0.000356	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	8.31e-05	0.000353	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.29e-05	0.000352	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.27e-05	0.000351	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.07e-05	0.000342	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.89e-05	0.000335	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.79e-05	0.000331	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.72e-05	0.000328	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	7.42e-05	0.000315	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.4e-05	0.000314	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.37e-05	0.000313	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	7.27e-05	0.000309	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	7.26e-05	0.000308	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.22e-05	0.000307	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.22e-05	0.000306	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	7.21e-05	0.000306	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.21e-05	0.000306	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	7.2e-05	0.000306	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	7.1e-05	0.000301	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.05e-05	0.000299	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7e-05	0.000297	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.88e-05	0.000292	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	6.86e-05	0.000291	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.81e-05	0.000289	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.81e-05	0.000289	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.75e-05	0.000287	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.6e-05	0.00028	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.6e-05	0.00028	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—EP300—attention deficit hyperactivity disorder	6.57e-05	0.000279	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.48e-05	0.000275	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.42e-05	0.000273	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	6.28e-05	0.000267	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	6.24e-05	0.000265	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.05e-05	0.000257	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.77e-05	0.000245	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.61e-05	0.000238	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.57e-05	0.000236	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.57e-05	0.000236	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.57e-05	0.000236	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.49e-05	0.000233	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.48e-05	0.000233	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.48e-05	0.000232	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.44e-05	0.000231	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.4e-05	0.000229	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	5.16e-05	0.000219	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	5.12e-05	0.000217	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	5.11e-05	0.000217	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.09e-05	0.000216	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	5.08e-05	0.000216	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—EP300—attention deficit hyperactivity disorder	4.96e-05	0.00021	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.93e-05	0.000209	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—EP300—attention deficit hyperactivity disorder	4.77e-05	0.000203	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.45e-05	0.000189	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	4.37e-05	0.000186	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	4.34e-05	0.000184	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	4.34e-05	0.000184	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	4.3e-05	0.000183	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.24e-05	0.00018	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.21e-05	0.000179	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	3.95e-05	0.000168	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.71e-05	0.000158	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.37e-05	0.000143	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.35e-05	0.000142	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	3.18e-05	0.000135	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.12e-05	0.000132	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	3.11e-05	0.000132	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	2.94e-05	0.000125	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	2.7e-05	0.000114	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.41e-05	0.000102	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.35e-05	9.97e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.21e-05	9.39e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.19e-05	9.31e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.87e-05	7.96e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.45e-05	6.14e-05	CbGpPWpGaD
